Immunocytochemical analysis of cisplatin induced platinum-DNA adducts with double-fluorescence video microscopy

British Journal of Cancer

Volumn 76, Issue 3, 1997, Pages 290-298

  Meijer, C ^a   De Vries, E G E ^a   Dam, W A ^a   Wilkinson, M H F ^a   Hollema, H ^a   Hoekstra, H J ^a   Mulder, N H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cisplatin; Histochemistry; Image analysis; Immunocytochemistry; Platinum DNA adducts; Polyclonal antibody

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CARBOPLATIN; CISPLATIN; DNA; DNA ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; PLATINUM; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CHEEK; COLON TUMOR; CONTROLLED STUDY; DNA ADDUCT; DNA DRUG COMPLEX; DNA MODIFICATION; DRUG RESISTANCE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; TESTIS TUMOR; TUMOR BIOPSY; TUMOR CELL LINE; VIDEORECORDING;

EID: 0030838481     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.381     Document Type: Article

References (41)

1. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43
2. Bedford P, Fichtinger-Schepman AMJ, Shellard SA, Walker C, Masters JRW and Hill BT (1988) Differential repair of platinum-DNA adducts in human bladder and testicular tumour continuous cell lines. Cancer Res 48: 3019-3024
3. Blommaert FA, Michael C, Terheggen PMAB, Muggia FM, Kortes V, Schornagel JH, Hart AAM and Den Engelse L (1993) Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variations and correlation with disease response. Cancer Res 53: 5669-5675
4. Chao CC-K, Shieh T-C and Huang H (1994) Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum(II) in vivo and in vitro. FEBS Lett 354: 103-109
5. Dabholkar M, Bradshaw L, Parker RJ, Gill I, Bostick-Bruton F, Muggia FM and Reed E (1992) Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro. Environmental Health Perspectives 98: 53-59
6. Fichtinger-Schepman AMJ, Baan RA, Luiten-Schuite A, Van Dijk M and Lohman PHM (1985) Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum(II) and analysis of adducts-related DNA-unwinding. Chem Biol Interactions 55: 275-288
7. Fichtinger-Schepman AMJ, Van Oosterom AT, Lohman PHM and Berends F (1987) Cisplatin-induced DNA adducts in peripheral leucocytes from seven cancer patients; quantitative immunochemical detection of the adduct induction and removal after a single dose of cisplatin. Cancer Res 47: 3000-3004
8. Fichtinger-Schepman AMJ, Baan RA and Berends F (1989) Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels. Carcinogenenis 10: 2367-2369
9. Fichtinger-Schepman AMJ, Van der Velde-Visser SD, Van Dijk-Knijnenburg HCM, Van Oosterom AT, Baan RA and Berends F (1990) Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumour tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation. Cancer Res 50: 7887-7894
10. Fry AM, Chresta CM, Davies SM, Walker MC, Harris JAL, Hartley JA, Masters JR and Hickson ID (1991) Relationship between topoisomerase II level and chemosensitivity in human tumour cell lines. Cancer Res 51: 6592-6595
11. Gill I, Muggia FM, Terheggen PMAB, Michael C, Parker RJ, Kortes V, Grunberg S, Christian MC, Reed E and Den Engelse L (1991) Dose-escalation study of carboplalin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum-DNA adducts. Ann Oncol 2: 115-121
12. Guchelaar H-J, Hoekstra HJ, De Vries EGE, Uges DRA, Oosterhuis JW and Schraffordt Koops H (1992) Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities. Br J Cancer 65: 898-902
13. Hamburger AW and Salmon SE (1977) Primary bioassay of human tumour stem cells. Science 197: 461-463
14. Hospers GAP, Mulder NH, De Jong B, De Leij L, Uges DRA, Fichtinger-Schepman AMJ, Scheper RJ and De Vries EGE (1988) Characterization of a human small cell lung carcinoma cell line with acquired cisplatin resistance in vitro. Cancer Res 48: 6803-6807
15. Hospers GAP, Meijer C, De Leij L, Uges DRA, Mulder NH and De Vries EGE (1990) A study of human small cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance. Int J Cancer 46: 138-144
16. Kittler J, Illingworth J and Föglein J (1985) Threshold selection based on a simple image statistic. Comp Vision Graph Image Proc 30: 125-147
17. Lippard SJ, Ushay HM, Merkel CM and Poirier MC (1983) Use of antibodies to probe the stereochemistry of antitumour platinum drug binding to deoxyribonucleic acid. Biochemistry 22: 5165-5168
18. Lochrer PJ and Einhorn LH (1984) Cisplatin. Ann Intern Med 100: 704-713
19. Meijer C, Mulder NH, Hospers GAP, Uges DRA and De Vries EGE (1990) The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62: 72-77
20. Mosman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
21. Parker RJ, Gill I, Tarone R, Vionnet JA, Grunberg S, Muggia FM and Reed E (1991) Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis 12: 1253-1258
22. Pielers R, Huismans DR, Loonen AH, Hählen K, Van der Does-van den Berg A, Van Wering ER and Veerman AJP (1991) Relation of cellular drug resistance to long-term clinical outcome in childhood acute leukaemia. Lancet 338: 399-403
23. Plooy ACM, Fichtinger-Schepman AMJ, Schutte HH, Van Dijk M and Lohman PHM (1985) The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Carcinogenesis 6: 561-566
24. Poirier MC, Lippard SJ, Zwelling LA, Ushay HM, Kerrigan D, Thill CC, Santella RM, Grunberger D and Yuspa SH (1982) Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci USA 79: 6443-6447
25. Poirier MC, Reed E, Zwelling LA, Ozols RF, Litterst CL and Yuspa SH (1985) Polyclonal antibodies to quantitate cis-diamminedichloro-platinum(II)-modified DNA adducts in cancer patients and animal models. Environmental Health Perspectives 62: 89-94
26. Poirier MC, Reed E, Ozols RF, Fasy T and Yuspa SH (1987) DNA adducts of cisplatin in nucleated peripheral blood cells and tissues of cancer patients. Prog Exp Tumour Res 31: 104-113
27. Poirier MC, Reed E, Litterst CL, Katz D and Gupta-Burt S (1992) Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res 52: 149-153
28. Reed E, Yuspa SH, Zwelling LA, Ozols RF and Poirier MC (1986) Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest 77: 545-550
29. Reed E, Ozols RF, Tarone R, Yuspa SH and Poirier MC (1987) Platinum-DNA adducts in leucocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci USA 84: 5024-5028
30. Reed E, Ozols RF, Tarone R, Yuspa SH and Poirier MC (1988) The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis 9: 1909-1911
31. Reed E, Ostchega Y, Steinberg SM, Yuspa SH, Young RC, Ozols RF and Poirier MC (1990) Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients. Cancer Res 50: 2256-2260
32. Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R and Muggia FM (1993) Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res 53: 3694-3699
33. Sark MWJ, Timmer-Bosscha H, Meijer C, Uges DRA, Sluiter WJ, Peters WHM, Mulder NH and De Vries EGE (1995) Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. Br J Cancer 71: 684-690
34. Sundquist WI, Lippard SJ and Stollar BD (1987) Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). Proc Natl Acad Sci USA 84: 8225-8229
35. Terheggen PMAB, Floot BGL, Scherer E, Begg AC, Fichtinger-Schepman AMJ and Den Engelse L (1987) Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections. Cancer Res 47: 6719-6725
36. Terheggen PMAB, Dijkman R, Begg AC, Dubbelman R, Floot BGJ, Hart AAM and Den Engelse L (1988) Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine (1,1-cyclobulanedicarboxylato)-platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Res 48: 5597-5603
37. Terheggen PMAB, Floot BGJ, Lempers ELM, Van Tellingen O, Begg AC and Den Engelse L (1991) Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides. Cancer Chemother Pharmacol 28: 185-191
38. Tilby MJ, Johnson C, Knox RJ, Cordell J, Roberts JJ and Dean CJ (1991) Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res 51: 123-129
39. Weisenthal LM, Marsden JA, Dill PL and Macaluso CK (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumours. Cancer Res 43: 749-757
40. Wilkinson MHF, Junsen GJ and Van der Waaij D (1993) Very low level fluorescence detection and imaging using a long exposure charge coupled device system. In Biotechnology applications of microinjection, microscopic imaging and fluorescence. Bach PH, Reynolds CH, Clark JM, Poole PL and Mottley J. (eds.), pp. 221-230. Plenum Press: New York
41. Wilkinson MHF, Jansen GJ and Van dor Waaij D (1994) Computer processing of microscopic images of bacteria: morphometry and fluorimetry. Trends Microbiol 2: 485-489